Cost Effectiveness of Secukinumab for the Treatment of Active Ankylosing Spondylitis in the UK
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1179-2027
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Cost Effectiveness of Secukinumab for the Treatment of Active Ankylosing Spondylitis in the UK ; volume:36 ; number:8 ; day:25 ; month:5 ; year:2018 ; pages:1015-1027 ; date:8.2018
PharmacoEconomics ; 36, Heft 8 (25.5.2018), 1015-1027, 8.2018
- Creator
-
Emery, Paul
- Contributor
-
Keep, Marjolijn Van
Beard, Steve
Graham, Chris
Miles, LaStella
Jugl, Steffen Marc
Gunda, Praveen
Halliday, Anna
Marzo-Ortega, Helena
SpringerLink (Online service)
- DOI
-
10.1007/s40273-018-0675-9
- URN
-
urn:nbn:de:101:1-2018090221041305341208
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:37 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Emery, Paul
- Keep, Marjolijn Van
- Beard, Steve
- Graham, Chris
- Miles, LaStella
- Jugl, Steffen Marc
- Gunda, Praveen
- Halliday, Anna
- Marzo-Ortega, Helena
- SpringerLink (Online service)
Other Objects (12)
Secukinumab: A Review in Ankylosing Spondylitis
Correction to: Secukinumab: A Review in Ankylosing Spondylitis
Secukinumab in Ankylosing Spondylitis Patients: A Cost-per-Responder Analysis from the Indonesian Health System Perspective
Cost-Effectiveness of Golimumab in Ankylosing Spondylitis from the UK Payer Perspective
A Pooled Analysis Reporting the Efficacy and Safety of Secukinumab in Male and Female Patients with Ankylosing Spondylitis
Scoring radiographic progression in ankylosing spondylitis: should we use the modified Stoke Ankylosing Spondylitis Spine Score (mSASSS) or the Radiographic Ankylosing Spondylitis Spinal Score (RASSS)?
Andersson lesion in ankylosing spondylitis
Spinal radiographic progression over 2 years in ankylosing spondylitis patients treated with secukinumab: a historical cohort comparison
Normative values for the bath ankylosing spondylitis functional index in the general population compared with ankylosing spondylitis patients in Morocco
Efficacy and NSAID-sparing effect of secukinumab 150 mg in ankylosing spondylitis : results from phase IV ASTRUM study
Surgical treatment of ankylosing spondylitis deformity
Ankylosierende Spondylitis: Secukinumab lindert Fatigue schnell und anhaltend
Secukinumab: A Review in Ankylosing Spondylitis
Correction to: Secukinumab: A Review in Ankylosing Spondylitis
Secukinumab in Ankylosing Spondylitis Patients: A Cost-per-Responder Analysis from the Indonesian Health System Perspective
Cost-Effectiveness of Golimumab in Ankylosing Spondylitis from the UK Payer Perspective
A Pooled Analysis Reporting the Efficacy and Safety of Secukinumab in Male and Female Patients with Ankylosing Spondylitis
Scoring radiographic progression in ankylosing spondylitis: should we use the modified Stoke Ankylosing Spondylitis Spine Score (mSASSS) or the Radiographic Ankylosing Spondylitis Spinal Score (RASSS)?
Andersson lesion in ankylosing spondylitis
Spinal radiographic progression over 2 years in ankylosing spondylitis patients treated with secukinumab: a historical cohort comparison
Normative values for the bath ankylosing spondylitis functional index in the general population compared with ankylosing spondylitis patients in Morocco
Efficacy and NSAID-sparing effect of secukinumab 150 mg in ankylosing spondylitis : results from phase IV ASTRUM study
Surgical treatment of ankylosing spondylitis deformity
Ankylosierende Spondylitis: Secukinumab lindert Fatigue schnell und anhaltend
Secukinumab: A Review in Ankylosing Spondylitis
Correction to: Secukinumab: A Review in Ankylosing Spondylitis
Secukinumab in Ankylosing Spondylitis Patients: A Cost-per-Responder Analysis from the Indonesian Health System Perspective
Cost-Effectiveness of Golimumab in Ankylosing Spondylitis from the UK Payer Perspective
A Pooled Analysis Reporting the Efficacy and Safety of Secukinumab in Male and Female Patients with Ankylosing Spondylitis
Scoring radiographic progression in ankylosing spondylitis: should we use the modified Stoke Ankylosing Spondylitis Spine Score (mSASSS) or the Radiographic Ankylosing Spondylitis Spinal Score (RASSS)?
Andersson lesion in ankylosing spondylitis
Spinal radiographic progression over 2 years in ankylosing spondylitis patients treated with secukinumab: a historical cohort comparison
Normative values for the bath ankylosing spondylitis functional index in the general population compared with ankylosing spondylitis patients in Morocco
Efficacy and NSAID-sparing effect of secukinumab 150 mg in ankylosing spondylitis : results from phase IV ASTRUM study
Surgical treatment of ankylosing spondylitis deformity